LINC02860: A Long Intergenic Non-Protein Coding RNA (G285941)

Target Name: LINC02860

NCBI ID: G285941

Other Name(s): long intergenic non-protein coding RNA 2860 | Putative uncharacterized protein C7orf71 | Chromosome 7 open reading frame 71 | C7orf71

LINC02860: A Long Intergenic Non-Protein Coding RNA

LINC02860 is a long non-coding RNA (lncRNA) that has been identified in various studies as a potential drug target or biomarker. It is a transcribed RNA molecule that is longer than 200 nucleotides and can be expressed in various cell types. LINC02860 is located between the genes PPT2 and PPT3, which encode for the protein PPT2 and PPT3, respectively.

The Importance of LINC02860 as a Drug Target

LINC02860 has been shown to be involved in various cellular processes, including cell growth, differentiation, and survival. Several studies have demonstrated that LINC02860 plays a critical role in the regulation of cell proliferation and has been associated with the development of various diseases, such as cancer.

One of the key features of LINC02860 is its ability to interact with various protein molecules, including tyrosine kinases, which are known to play a crucial role in cell signaling. LINC02860 has been shown to regulate the activity of several tyrosine kinases, including PDGFR-尾, TYRO30, and Src.

In addition to its role in tyrosine kinase regulation, LINC02860 has also been shown to play a critical role in the regulation of cell adhesion. LINC02860 has been shown to interact with the protein ZF-Y66 and has been shown to regulate the activity of the protein Focal Adhesion Runtime (FAR), which is involved in cell-cell adhesion.

The Potential Applications of LINC02860 as a Biomarker

The potential applications of LINC02860 as a biomarker are vast and varied. One of the key advantages of LINC02860 is its ability to be easily purified and sequenced, which makes it an ideal candidate for use as a diagnostic or research tool.

In addition to its potential as a biomarker, LINC02860 has also been shown to be involved in various diseases and has been identified as a potential drug target. For example, LINC02860 has been shown to be involved in the regulation of cell proliferation and has been associated with the development of various cancer types.

In addition to its potential as a cancer drug target, LINC02860 has also been shown to be involved in the regulation of other cellular processes, including cell adhesion and differentiation. LINC02860 has been shown to regulate the activity of several transcription factors, including NF-kappa-B and SMAD, and has been shown to play a critical role in the regulation of gene expression.

Conclusion

In conclusion, LINC02860 is a long non-coding RNA that has been shown to be involved in various cellular processes and has been identified as a potential drug target or biomarker. Its ability to be easily purified and sequenced makes it an ideal candidate for use as a diagnostic or research tool, and its potential applications in the regulation of cell proliferation and adhesion make it a promising candidate for further study. Further research is needed to fully understand the role of LINC02860 in cellular processes and its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2860

More Common Targets